Progresses in Gene Therapy of Neurodegenerative Disorders

Journal Title: Online Journal of Neurology and Brain Disorders - Year 2018, Vol 1, Issue 1

Abstract

Gene therapy is a technique that uses genes to treat or prevent diseases. Gene therapy to the brain faces other difficulties in addition to the general issues one faces with gene therapy. A major limiting factor for the delivery of gene to the brain is the blood brain barrier (BBB), which most gene expression vectors can not cross naturally. However, recent advances in gene transfer technology have led to promises for delivery of therapeutic genes to brain. In this small review we shall make a discussion on the recent developments of gene therapies for some important neurodegenerative disorders. Gene therapy is the administration of genetic material into the somatic cells of a patient that exerts therapeutic effects by correcting genetic defects, over expression of desired proteins or inhibition of the expression of unwanted harmful proteins [1]. For primary neurodegenerative disorders patient's condition progressively deteriorated and the current therapies remain limited to symptomatic treatments [2]. The presence of blood-brain barrier (BBB) prevents the delivery of therapeutic agents to the brain [3]. However, recent advances in gene transfer technologies show promise for delivery of therapeutic genes to brain for the replacement of defective proteins, neuroprotection, restoration of neuronal functions etc [2]. With the advent in the understanding the molecular pathologies, it is anticipated that the therapeutic genes have the ability of revolutionize the management of human diseases [4].

Authors and Affiliations

Ashim Kumar Basak, Tridip Chatterjee

Keywords

Related Articles

Distribution of Multilayered Fiber Terminals in the Human Cerebellar Cortex. Visualization by Immunohistochemistry for Histamine

The distribution of histamine in the human cerebellar cortex was studied by light microscope immunohistochemistry using a rabbit polyclonal antibody anti-histamine. In all layers of the cerebellar cortex, were revealed p...

The Digitalization of the Human Memory

The pace that Information and Communication Technologies (ICTs) have evolved and revolutionized the society maroon’s human memory in a tumultuous sea of change, unpredictable and unstable. The future has been yanked out...

Rituximab-Rescue Therapy in Autoimmune Neurological Disorders

Demyelinating diseases like Multiple Sclerosis and cases of long segment myelitis, neuromuscular disease like Myasthenia Gravis and Autoimmune Encephalitis have an autoimmune basis and occur in a relapsing remitting cour...

Progresses in Gene Therapy of Neurodegenerative Disorders

Gene therapy is a technique that uses genes to treat or prevent diseases. Gene therapy to the brain faces other difficulties in addition to the general issues one faces with gene therapy. A major limiting factor for the...

Mindset Kinetics and Crime Behavior- Quantitative Methods? A New Forensic Quantitative Approach. How Biochemistry, Toxicology, Imaging Principle Can Help in Jurisdictional Settings

In some non-voluntary crime is crucial verify the amygdala and limbic system physio-pathology of human responsible of the facts under a Jurisdictional contest. But is relevant to verify this condition in really objective...

Download PDF file
  • EP ID EP590686
  • DOI 10.32474/OJNBD.2018.01.000103
  • Views 79
  • Downloads 0

How To Cite

Ashim Kumar Basak, Tridip Chatterjee (2018). Progresses in Gene Therapy of Neurodegenerative Disorders. Online Journal of Neurology and Brain Disorders, 1(1), 6-8. https://europub.co.uk./articles/-A-590686